#biotelemetry

Philips to buy BioTelemetry for $2.8 billion

Royal Philips on Friday announced plans to purchase a remote cardiac diagnostics and monitoring company for an estimated $2.8 billion. The transaction, under which Philips plans to acquire Malvern, Pa.-based company BioTelemetry for $72 per share in cash, is expected to close in the first quarter of 2021. BioTelemetry sells wearable heart monitors and analytics services that detect abnormal heart…

Philips Acquires Remote Cardiac Monitoring BioTelemetry for $2.8B

What You Should Know: – Philips acquires BioTelemetry, a U.S. provider of remote cardiac diagnostics and monitoring for $72.00 per share for an implied enterprise value of $2.8 billion (approx. EUR 2.3 billion). – With $439M in revenue in 2019, BioTelemetry annually monitors over 1 million cardiac patients remotely; its portfolio includes wearable heart monitors, AI-based data analytics, and…

Earnings: BioTelemetry stock trades higher ahead of Q2 report

Medical technology company BioTelemetry, Inc. (NASDAQ: BEAT) is scheduled to publish its second-quarter 2019 earnings in a short while from now. Analysts’ consensus earnings estimate for the quarter is $0.45 per share, which represents a 2% year-over-year decline. Meanwhile, revenues are forecast to grow about 10% to $111.11 million.

In the March quarter, the company completed the acquisition…

Increasing Potential of the North America Digital Health Monitoring Devices Market Outlook: Ken Research

Buy Now

The digital health plays an important role in enhancing the health related issues in the modern healthcare segment with the significant rise in the urbanization and development in the digital health monitoring devices. The telehealth and telecare services are the most utilized services in the digital health care segment for considering the health regarding issues and that is done by…

BioTelemetry (BEAT:NAS) Fundamental Valuation Report

Fundamental Valuation Report

BioTelemetry(BEAT:NAS) Healthcare:Diagnostics & Research

This Report was generated…

(Nasdaq:BEAT) BioTelemetry, Inc. Breaks 52 Week High Record Of $44.20

BioTelemetry, Inc. (Nasdaq:BEAT)

June 6th, 2018

With markets going up BioTelemetry, Inc. closed the day up $0.50 Wednesday, a 1.15% increase, closing at $44.15. In addition it hit a new 52 week high of $44.20. Be aware that the Piotroski Score1 is calculated to be 2, which is very low as the scale goes from 0-9. This is considered to be a weak score in terms of financial strength.

BEAT was…